CClinicalTrials.gg
CompletedNCT03116334Updated Apr 18, 2017

Genetic Influences Between Cognitive Function and BMI

An observational study in Obesity, sponsored by Baylor College of Medicine. Completed at 1 site in United States. Open to participants aged 7 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-18.

Sponsored by Baylor College of Medicine · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
869
Ages
7 Years to 15 Years
Sex
All
01

Study summary

In this study the investigators will interrogate an existing data set to examine whether genetic variants contribute to an inverse association between weight status and cognitive function. Investigators hypothesize that body mass index (BMI) will be inversely related to a number of variables measuring cognitive function, and that that this inverse relation will be at least partially attributable to genetic variants which influence both BMI and cognition.

Read the detailed description

Investigators will use existing data collected as part of the Texas Twin Project (TTP). TTP collected neuropsychological task data on cognition (executive functioning and general cognitive abilities) from a computerized test battery, as well as BMI data, on a sample of 869 twins. Investigators will use information from the known extent of genetic and environmental sharing between members of MZ (monozygotic; identical) and DZ (dizygotic; fraternal) twin pairs to quantify the genetic correlation between measures of cognition and BMI using biometric genetic modeling under the assumptions of the classical twin model. The specific aims are:

  • To examine the association between BMI and executive functioning (EF) in a sample of 869 twin children, ages 7 to 15 years old, who participated in the Texas Twin Project (TTP)
  • To gauge the specificity of EF-BMI relations relative to academic achievement and general cognitive abilities.
  • To examine the relative contribution of genetic and environment influences to the inverse association between BMI and EF
02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • Obesity
  • BMI
  • executive functioning
  • general cognitive ability
  • twin study
  • heritability
  • cognition
  • GCTA
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 869 is above the median of 135 across 1,283 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Baylor College of Medicine is the lead sponsor of 734 studies on the registry; 110 are open to participants now.

Of its 83 completed or terminated interventional studies of FDA-regulated products, 44 (53%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals from the Texas twin Project dataset, who were twins and higher-order multiples previously recruited from the Houston and Austin Metropolitan areas, via flyers, the internet (study website) and contact through public school rosters

Inclusion criteria

All participants in the TTP database with executive functioning and BMI data, without a parent-reported medical disorder affecting growth

Exclusion criteria

Exclusion Criteria:

Parent-reported medical disorder affecting growth More than one sibling in the dataset (if triplets are present, only two randomly selecting siblings will be included).

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
869 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Executive functioning

    This measure will be derived from a computerized test battery incorporating the Animal Stroop, Stop Signal, Mickey (an anti- Trail Making, Local-Global, Plus-Minus, Digit Span Backward, Symmetry Span, Listening Recall, 2-Back, Keeping Track, and Running Memory for Letters tasks. A latent factor of variance common to all these tasks will be used to indicate "higher order executive functioning".

    Time frame: 2 hours

  2. Body mass index

    Heights and weights were measured by trained study personnel and BMI will be calculated as weight in kilograms (kg) divided by height in centimeters (cm) squared.

    Time frame: 10 minutes

Secondary outcomes

  1. General Cognitive Ability

    This was assessed using the WASI-II

    Time frame: 1 hour

  2. Academic Achievement

    This was assessed using the Woodcock-Johnson-III Calculations and Passage Comprehension tests

    Time frame: 30 minutes

07

Study locations

1 site
  • Children's Nutrition Research Center
    Houston, Texas 77030, United States
08

References and documents

Individual participant data

Plan to share: No — This protocol involves secondary data analysis of existing studies. Data will not be shared with other investigators since they should obtain data from the primary sources.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03116334
Lead sponsor
Baylor College of Medicine
Responsible party
Alexis Wood (Assistant Professor, Baylor College of Medicine) — Principal investigator
First posted
Apr 17, 2017
Start date
Sep 2009
Primary completion
Dec 2016
Completion
Dec 2016
Last update
Apr 18, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion